Correlation Between Entrada Therapeutics and Rallybio Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Entrada Therapeutics and Rallybio Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entrada Therapeutics and Rallybio Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entrada Therapeutics and Rallybio Corp, you can compare the effects of market volatilities on Entrada Therapeutics and Rallybio Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entrada Therapeutics with a short position of Rallybio Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entrada Therapeutics and Rallybio Corp.

Diversification Opportunities for Entrada Therapeutics and Rallybio Corp

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Entrada and Rallybio is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Entrada Therapeutics and Rallybio Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rallybio Corp and Entrada Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entrada Therapeutics are associated (or correlated) with Rallybio Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rallybio Corp has no effect on the direction of Entrada Therapeutics i.e., Entrada Therapeutics and Rallybio Corp go up and down completely randomly.

Pair Corralation between Entrada Therapeutics and Rallybio Corp

Given the investment horizon of 90 days Entrada Therapeutics is expected to generate 0.92 times more return on investment than Rallybio Corp. However, Entrada Therapeutics is 1.09 times less risky than Rallybio Corp. It trades about 0.19 of its potential returns per unit of risk. Rallybio Corp is currently generating about 0.0 per unit of risk. If you would invest  1,699  in Entrada Therapeutics on August 26, 2024 and sell it today you would earn a total of  181.00  from holding Entrada Therapeutics or generate 10.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Entrada Therapeutics  vs.  Rallybio Corp

 Performance 
       Timeline  
Entrada Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Entrada Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental indicators, Entrada Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.
Rallybio Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rallybio Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Entrada Therapeutics and Rallybio Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Entrada Therapeutics and Rallybio Corp

The main advantage of trading using opposite Entrada Therapeutics and Rallybio Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entrada Therapeutics position performs unexpectedly, Rallybio Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rallybio Corp will offset losses from the drop in Rallybio Corp's long position.
The idea behind Entrada Therapeutics and Rallybio Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance